doxorubicin (Ambrilia)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedoxorubicin (Ambrilia)
Drug Alias Namedoxorubicin-NGR peptide-targeting ligand conjugate (Ambrilia)doxorubicinTVT-Doxdoxorubicin (Bioxalis)doxorubicin-NGR peptide-targeting ligand conjugate (Bioxalis)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAminopeptidase N modulatorsTopoisomerase II inhibitorsVirus DNA polymerase inhibitors
TargetsVirus DNA polymeraseTopoisomerase IIAminopeptidase N
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioxalis Medica Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioxalis Medica IncAmbrilia Biopharma Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A